Stock ATXI AVENUE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Avenue Therapeutics, Inc.

Equities

ATXI

US05360L4032

Delayed Nasdaq
Other stock markets
 19:46:39 26/06/2024 BST 		5-day change 1st Jan Change
3.697 USD +3.27% Intraday chart for Avenue Therapeutics, Inc. +8.11% -69.38%
05-16 Avenue Therapeutics, Inc Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) CI
05-15 Avenue Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. ATXI Stock
  4. Revisions Avenue Therapeutics, Inc.